RASAGILINE

Generic: RASAGILINE MESYLATE

Rising Pharma HoldingsManufacturer
ORALRoute
RASAGILINE MESYLATEActive Substance
2024-04-09Original Approval

RASAGILINE is FDA application ANDA218163, sponsored by RISING. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2022-12-28
Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30; Manufactured by Alkem Laboratori

Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the t

Top Reported Reactions

1
HALLUCINATION
447 reports
2
FALL
421 reports
3
DRUG INEFFECTIVE
345 reports
4
DYSKINESIA
323 reports
5
DEATH
286 reports
6
DIZZINESS
277 reports
7
TREMOR
254 reports
8
PARKINSON^S DISEASE
246 reports
9
CONSTIPATION
235 reports
10
GAIT DISTURBANCE
232 reports